Abstract
Clonazepam has some evidence in the treatment of tardive dyskinesia. It can be used as an alternative treatment option insituations where vesicular monoamine transporter 2 inhibitors are not available or when it is not feasible to use them.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
